Zealand Pharma Statistics
Total Valuation
Zealand Pharma has a market cap or net worth of DKK 62.88 billion. The enterprise value is 53.53 billion.
Market Cap | 62.88B |
Enterprise Value | 53.53B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Zealand Pharma has 70.94 million shares outstanding. The number of shares has increased by 16.42% in one year.
Shares Outstanding | 70.94M |
Shares Change (YoY) | +16.42% |
Shares Change (QoQ) | +1.72% |
Owned by Insiders (%) | 0.32% |
Owned by Institutions (%) | 47.57% |
Float | 60.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 145.15 |
PB Ratio | 6.69 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -75.18 |
EV / Sales | 145.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -102.08 |
Financial Position
The company has a current ratio of 35.57, with a Debt / Equity ratio of 4.15.
Current Ratio | 35.57 |
Quick Ratio | 35.20 |
Debt / Equity | 4.15 |
Debt / EBITDA | n/a |
Debt / FCF | -0.74 |
Interest Coverage | -33.62 |
Financial Efficiency
Return on equity (ROE) is -12.80% and return on invested capital (ROIC) is -7.75%.
Return on Equity (ROE) | -12.80% |
Return on Assets (ROA) | -7.38% |
Return on Capital (ROIC) | -7.75% |
Revenue Per Employee | 1.28M |
Profits Per Employee | -2.47M |
Employee Count | 253 |
Asset Turnover | 0.06 |
Inventory Turnover | 104.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +239.40% in the last 52 weeks. The beta is 0.64, so Zealand Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | +239.40% |
50-Day Moving Average | 894.84 |
200-Day Moving Average | 619.16 |
Relative Strength Index (RSI) | 51.39 |
Average Volume (20 Days) | 385,555 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zealand Pharma had revenue of DKK 367.97 million and -712.00 million in losses. Loss per share was -11.82.
Revenue | 367.97M |
Gross Profit | -346.47M |
Operating Income | -720.72M |
Pretax Income | -716.56M |
Net Income | -712.00M |
EBITDA | -713.21M |
EBIT | -720.72M |
Loss Per Share | -11.82 |
Balance Sheet
The company has 8.93 billion in cash and 389.99 million in debt, giving a net cash position of 9.36 billion or 131.92 per share.
Cash & Cash Equivalents | 8.93B |
Total Debt | 389.99M |
Net Cash | 9.36B |
Net Cash Per Share | 131.92 |
Equity (Book Value) | 9.40B |
Book Value Per Share | 132.48 |
Working Capital | 8.89B |
Cash Flow
In the last 12 months, operating cash flow was -508.19 million and capital expenditures -16.18 million, giving a free cash flow of -524.37 million.
Operating Cash Flow | -508.19M |
Capital Expenditures | -16.18M |
Free Cash Flow | -524.37M |
FCF Per Share | -7.39 |
Margins
Gross margin is -94.16%, with operating and profit margins of -195.86% and -193.49%.
Gross Margin | -94.16% |
Operating Margin | -195.86% |
Pretax Margin | -194.73% |
Profit Margin | -193.49% |
EBITDA Margin | -193.82% |
EBIT Margin | -195.86% |
FCF Margin | -142.50% |
Dividends & Yields
Zealand Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.42% |
Shareholder Yield | -16.42% |
Earnings Yield | -1.33% |
FCF Yield | -0.83% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |